Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT)
CUSIP: 03969T109
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 28,423,877
- Total 13F shares
- 26,254,849
- Share change
- -348,602
- Total reported value
- $609,261,942
- Put/Call ratio
- 68%
- Price per share
- $23.21
- Number of holders
- 163
- Value change
- -$9,219,231
- Number of buys
- 77
- Number of sells
- 78
Quarterly Holders Quick Answers
What is CUSIP 03969T109?
CUSIP 03969T109 identifies ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03969T109:
Top shareholders of ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FEDERATED HERMES, INC. |
13F
|
Company |
17%
|
4,694,060
|
$114,300,361 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
9.3%
|
2,649,838
|
$64,523,556 | — | 30 Jun 2024 | |
| ARK Investment Management LLC |
13F
|
Company |
6.9%
|
1,964,964
|
$47,846,871 | — | 30 Jun 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
5.5%
|
1,563,065
|
$38,060,633 | — | 30 Jun 2024 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
5.5%
|
1,563,065
|
$37,966,849 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
5.4%
|
1,523,838
|
$37,105,455 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.9%
|
1,384,744
|
$33,718,517 | — | 30 Jun 2024 | |
| Ultragenyx Pharmaceutical Inc. |
3/4/5
|
Director |
—
class O/S missing
|
1,400,000
|
$26,208,420 | — | 10 Aug 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
3.2%
|
918,222
|
$22,358,901 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.8%
|
795,941
|
$19,381,164 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
2.7%
|
754,023
|
$18,360,460 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
2%
|
555,524
|
$13,527,010 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2%
|
555,024
|
$13,514,834 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
546,009
|
$13,298,392 | — | 30 Jun 2024 | |
| Portolan Capital Management, LLC |
13F
|
Company |
1.7%
|
484,907
|
$11,807,485 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.6%
|
445,541
|
$10,848,923 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.3%
|
360,749
|
$8,784,238 | — | 30 Jun 2024 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
1.2%
|
352,550
|
$8,584,593 | — | 30 Jun 2024 | |
| Granahan Investment Management, LLC |
13F
|
Company |
1.2%
|
344,549
|
$8,389,768 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
1%
|
283,420
|
$6,901,275 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.96%
|
272,007
|
$6,623,371 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.86%
|
244,154
|
$5,945,155 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.81%
|
230,315
|
$5,608,171 | — | 30 Jun 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.72%
|
205,552
|
$5,005,192 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.68%
|
194,398
|
$4,733,591 | — | 30 Jun 2024 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.63%
|
180,116
|
$4,385,825 | — | 30 Jun 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.53%
|
151,329
|
$3,684,861 | — | 30 Jun 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.46%
|
131,718
|
$3,207,333 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.46%
|
130,061
|
$3,166,986 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.42%
|
119,181
|
$2,902,058 | — | 30 Jun 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.36%
|
102,039
|
$2,484,650 | — | 30 Jun 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.35%
|
100,336
|
$2,443,182 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.32%
|
89,643
|
$2,182,808 | — | 30 Jun 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.27%
|
78,014
|
$1,899,641 | — | 30 Jun 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.26%
|
74,830
|
$1,822,111 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.26%
|
73,112
|
$1,780,277 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.26%
|
72,786
|
$1,772,340 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.24%
|
67,222
|
$1,636,855 | — | 30 Jun 2024 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.24%
|
67,466
|
$1,623,907 | — | 30 Jun 2024 | |
| HARBOR CAPITAL ADVISORS, INC. |
13F
|
Company |
0.23%
|
65,667
|
$1,599,000 | — | 30 Jun 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.22%
|
63,659
|
$1,550,097 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.22%
|
62,159
|
$1,513,572 | — | 30 Jun 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.22%
|
61,630
|
$1,501,000 | — | 30 Jun 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.19%
|
53,409
|
$1,300,509 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.17%
|
48,610
|
$1,183,654 | — | 30 Jun 2024 | |
| Swiss National Bank |
13F
|
Company |
0.17%
|
47,700
|
$1,161,495 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.16%
|
45,219
|
$1,101,083 | — | 30 Jun 2024 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.15%
|
43,889
|
$1,067,000 | — | 30 Jun 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.15%
|
43,501
|
$1,059,250 | — | 30 Jun 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.15%
|
41,947
|
$1,021,409 | — | 30 Jun 2024 |
Institutional Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q3 2024
As of 30 Sep 2024,
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) was held by
163 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,254,849 shares.
The largest 10 holders included
FEDERATED HERMES, INC., BlackRock, Inc., Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Group, Inc., ARK Investment Management LLC, VANGUARD GROUP INC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Woodline Partners LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
163
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
169
Q3 2024 holders
163
Holder diff
-6
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.